Clinical Trial

Exosomes Effect on Visual Function in CVI

Completed
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to learn about the effects of nazally applied exosome treatment on visual functions in children with Phase 1 Cerebral visual impairment (CVİ). The main question it aims to answer is: Does exosome therapy administered via the nasal route for neurological disorders in children with Phase 1 CVI also show a beneficial effect on visual functions? Researchers will compare visual and visual function findings before and after the exosome application to determine whether the exosome application is also effective in visual function. Participants: * They will receive exosomes via the nasal route every month for 6 months. * They will visit the clinic every month for monitoring and tests.
Trial Details
NCT Number NCT07492966
Lead Sponsor Hatice Semrin Timlioglu İper
Conditions Cortical Visual Impairment, Visual Function
Enrollment 32 participants
Start Date 2024-06-30
Primary Completion 2025-07-19 (estimated)
Study Completion 2025-09-24 (estimated)
Updated on ClinicalTrials.gov 2026-03-25